Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    EU regulator recommends positive opinion of AstraZeneca’s experimental breast cancer drug

    Picture of AstraZeneca logoAstraZeneca
    22/05/2026 11:43
    May 22 (Reuters) - A European Medicines Agency committee said on Friday it has adopted a positive opinion of AstraZeneca’s AZN.L experimental breast cancer drug, camizestrant.

 (Reporting by Ankita Bora in Bengaluru; Editing by Tasim Zahid)

 ((Ankita.Bora@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news